Status:
UNKNOWN
Treatment of Myocardial Infarction With Bone Marrow Derived Stem Cells
Lead Sponsor:
Odense University Hospital
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
30-75 years
Phase:
PHASE1
Brief Summary
The aim of the study is to investigate whether infusion of autologous bone marrow derived stem cells can improve cardiac function in the aftermath of a myocardial infarction.
Detailed Description
Primary coronary intervention within a few hours of a myocardial infarction has greatly reduced mortality as well as the risk of developing chronic heart failure. There are though still a large number...
Eligibility Criteria
Inclusion
- Chestpain
- Troponin T, \> 0,1ng/ml
- Succesfull revascularization of culprit lesion with PCI.
- No more than stenosis of 2 major epicardiel coronary arteries.
Exclusion
- Cardiogenic shock
- Known LVEF\<45%
- Cardiomyopathy
- Atrialfibrillation or fluctuation
- Takyarytmia
- Infection
- Chronic inflammatory disease
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2007
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00275977
Start Date
February 1 2006
End Date
March 1 2007
Last Update
July 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of endocrinology M, Odense University Hospital
Odense, Denmark, 5000